Calliditas Receives FDA Fast Track Designation for setanaxib in PBC ...Middle East

STOCKHOLM, Aug. 9, 2021 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) for its lead NOX inhibitor candidate setanaxib for the...

Hence then, the article about calliditas receives fda fast track designation for setanaxib in pbc was published today ( Monday 09/08/2021 - 10:30 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Calliditas Receives FDA Fast Track Designation for setanaxib in PBC )

Also on site :

• LSG vs RCB Dream11 Prediction Today Match, Dream11 Team Today, Fantasy Cricket Tips, Playing XI, Pitch Report, Injury Update- IPL 2026, Match 50
• McDonald’s is about to report earnings. Here’s what to expect
• Germany’s new militarization: Revival of the spirit or blatant revanchism? (by Dmitry Medvedev)